Compliance Certificate under SEBI Regulations for Quarter Ended 30 Sep 2025
Shilpa Medicare Limited submits compliance certificate under SEBI Regulations for quarter ended 30 September 2025 from Kfin Technologies Limited.
This is a standard compliance filing and does not have a significant impact on the company's operations or stock price.
The announcement is a routine compliance disclosure, providing information about regulatory requirements.
* Shilpa Medicare Limited submits a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. * The certificate, dated 3 October 2025, is from M/s. Kfin Technologies Limited, the Registrar and Share Transfer Agent of Shilpa Medicare Limited. * It pertains to the quarter ended 30 September 2025, confirming the details of securities dematerialized/rematerialized have been furnished to all stock exchanges where the company's shares are listed.
What to do with a filing like this
Shilpa Medicare Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shilpa Medicare Limited. Read the original for the full detail.